Skip to main content Skip to footer
PipelineReview. Business Intellegence Center
  • Home
  • News Channels
    • All News
  • Reports
  • Press Room
  • Contact Us
  • About Us

Proteins and Peptides

News Channels

  • Antibodies
  • Proteins and Peptides
  • Vaccines
  • DNA RNA and Cells
  • Small Molecules
  • More News
  • All News

Newsletter

La Merie Biologics

La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.

SubscribeNewsletter La Merie Biologics

Newsletter

New Product Alert

La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.

SubscribeNewsletter new product alert

Featured reports

Denosumab (Prolia & Xgeva) Biosimilars Pipeline Review
Competitor Analysis: Complement C5 Inhibitors & C5 Receptor Antagonists
Adalimumab (Humira) Biosimilars Pipeline Review
B7-H4 Targeted Antibody Therapy Pipeline Review
Degrader-Antibody Conjugates 2024: A Landscape Analysis of Stakeholders, Technologies, Pipeline and Partnering from an Industry Perspective
GPC3-Targeted Immunotherapy Pipeline Review
T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis
Bispecific Antibodies for Immuno-Oncology & Other Diseases
CD40 Agonists & CD40/L Antagonists Pipeline Review
CCR8-Targeted Antibody Immunotherapy Pipeline Review
PipelineReview.com is powered by La Merie Business IntelligenceFor immediate assistance, please call us during business hours:
Mon-Fri 10:00am - 05:00pm; GMT+01
La Merie Publishing - Ulrich Martin
Veinat Puigsec - Can Magí s/n | 17862 Vallfogona de Ripollès | Spain | T +34-87-200 1365 | Email info@lamerie.com

All contents © by La Merie Publishing

  • Terms and Conditions
    Privacy Policy
    Submit your Press Release
    Imprint
Programa Kit Digital cofinanciado por los fondos Next Generation (EU)
del mecanismo de recuperación y resilencia
NextGeneration-EUPlan de recuperación, transformación y resilencia